POSSIBILITIES OF LOCAL THERAPY FOR LOW BACK PAIN
https://doi.org/10.17650/1818-8338-2014-1-91-95
Abstract
Low back pain (LBP) is one of the most common pain syndromes caused by musculoarticular pathology. Analgesics, nonsteroidal antiinflammatory drugs (NSAIDs), myorelaxants, and non-drug therapies are used to treat patients with LBP. The sufficient efficiency of this type of therapy is strongly supported by the results of clinical trials; its fundamentals have been embodied in a number of regional and international guidelines for the management of patients with LBP. Alongside the sufficient efficacy of NSAIDs, their use, their long-term use in particular, is associated with a wide range of adverse reactions. The increased efficiency of treatment in patients with LBP is frequently achieved by the application of topical dosage forms. Whether the new Russian drug Nanoplast forte may be used to treat patients with LBP is considered.
About the Authors
A. V. ChugunovRussian Federation
A. Yu. Chugunov
Russian Federation
kh. Ya. Umarova
Russian Federation
References
1. Есин Р.Г., Есин О.Р., Ахмадеева Г.Д., Салихова Г.В. Боль в спине. Казань: Казанский полиграфкомбинат, 2010.
2. Mafi J.N., McCarthy E.P., Davis R.B., Landon B.E. Worsening trends in the management and treatment of back pain. JAMA Intern Med 2013;173(17):1573–81.
3. Камчатнов П.Р., Чугунов А.В., Трубецкая Е.А. Пациент с болью в спине: возможности терапии. Нервно-мышечные болезни 2013;(2):20–7.
4. Garcia Rodriguez L.A., Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12(5):570–6.
5. Schaffer D., Florin T., Eagle C. et al. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust 2006;185(9):501–6.
6. Каратеев А.Е., Насонова В.А. НПВП-ассоциированная гепатопатия: проблема нимесулида. Науч-практ ревматол 2003;(4):87–91.
7. McGettigan P., Henry D. Use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med 2013;10(2):e1001388.
8. Fosbøl E.L., Folke F., Jacobsen S. et al. Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 2010;3(4):395–405.
9. Bavry A.A., Khaliq A., Gong Y. et al. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med 2011;124(7):614–20.
10. Батышева Т.Т., Отческая О.В., Хозова А.А. и др. Эффективность применения комбинации препаратов артрозан и комбилипен у пациентов с острой болью в нижней части спины. Журн неврол и психиатр им. С.С. Корсакова 2011; (9 выпуск 2):41–4.
11. Mason L., Moore R.A., Edwards J.E. et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004; (5):10.
12. http://nanoplast-forte.ru/products2.html.
13. Цветкова Е.С., Денисов Л.Н., Шостак Н.А., Шмидт Е.И. Трансдермальная терапия остеоартроза коленных суставов: новое направление. Consilium Medicum 2012;14(2):25–30.
14. Котова О.В. Альтернативные методы лечения боли в шее. Новая аптека 2011; (3):93–6.
15. Котова О.В. Боль в нижней части спины. Новая аптека 2012;(19):48–52.
16. Пилипович А.А. Болит спина – измени жизнь! Новая аптека 2012;(11):102–7.
17. Смирнова Е.А. Возвращая радость жизни без боли. Новая аптека 2013;(3): 64–7.
Review
For citations:
Chugunov A.V., Chugunov A.Yu., Umarova Kh.Ya. POSSIBILITIES OF LOCAL THERAPY FOR LOW BACK PAIN. The Clinician. 2014;8(1):91-95. (In Russ.) https://doi.org/10.17650/1818-8338-2014-1-91-95